UCB reports positive data from BE READY trial of bimekizumab
UCB has reported positive results from the Phase III BE READY clinical trial of its...
Read More...
Focus:
Belgium
-
![Themis Bioscience and CEPI trial Lassa fever vaccine]()
Themis Bioscience and CEPI trial Lassa fever vaccine
Themis Bioscience and the Coalition for Epidemic Preparedness Innovations (CEPI) have commenced a Phase I...
Read More...
-
![UCB’s Phase III trial of bimekizumab in psoriasis patients meets goals]()
UCB’s trial of bimekizumab in psoriasis patients meets goals
UCB has announced that the Phase III BE VIVID clinical trial of its bimekizumab met...
Read More...
-
![]()
Vaccitech begins Phase IIb universal flu vaccine trial in Belgium
UK-based Vaccitech has started treating patients with influenza A vaccine MVA-NP+M1 (VTP-100) in a Phase...
Read More...
-
![]()
MorphoSys and Galapagos launch Phase II atopic dermatitis trial
MorphoSys and Galapagos have commenced a Phase II clinical trial, in alliance with Novartis Pharma,...
Read More...
-
OSE Immunotherapeutics to study cancer drug in France and Belgium
OSE Immunotherapeutics has secured authorisation from the French and Belgian regulatory authorities to conduct a...
Read More...
-
argenx begins dosing in Phase III myasthenia gravis trial
Biotechnology company argenx has started dosing patients in a Phase III clinical trial of its...
Read More...
-
FluGen doses first subject in new study of M2SR for influenza
FluGen has dosed the first subject in a new clinical trial evaluating the M2SR vaccine...
Read More...
-
![]()
Alofisel (darvadstrocel) for the Treatment of Complex Perianal Fistulas in Crohn’s Disease
Alofisel® (formerly Cx601 / darvadstrocel) is the first allogeneic stem cell therapy to be approved...
Read More...
-
Deals this Week: Endocyte, vTv Therapeutics, Prothena
Endocyte Inc plans to issue shares of its common stock through an underwritten registered public...
Read More...